David Lawrence awarded millions from NIH to study light-activated therapeutics
Imagine the possibility of using light to active therapeutics when treating diseases – reducing the potential harsh side effects of aggressive disease treatments used today. That’s what Professor David Lawrence, Ph.D., at the UNC Eshelman School of Pharmacy is focused … Read more